Overall, based on the lipid profile results and metabolic analysis supported by molecular analysis, both carboxamide derivatives showed promising lipid-lowering activity and displayed regulatory activity of metabolic pathways that were disturbed by hyperlipidemia induction. The efficacy of carboxamide compounds was comparable to the conventional lipid-lowering drug, fenofibrate. Compound A exhibited superior activity significantly lowering triglycerides levels and restoring many of the metabolic alterations induced in hyperlipidemia.
Building similarity graph...
Analyzing shared references across papers
Loading...
Mohammad Alwahsh
Rahaf Alejel
Lama Hamadneh
Metabolomics
University of Jordan
Al-Balqa Applied University
Leibniz Institute for Analytical Sciences - ISAS
Building similarity graph...
Analyzing shared references across papers
Loading...
Alwahsh et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69db36a04fe01fead37c49bb — DOI: https://doi.org/10.1007/s11306-026-02426-4
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: